LSTA Annual ROE
-43.28%
+38.17%+46.86%
31 December 2023
Summary:
As of January 23, 2025, LSTA annual return on equity is -43.28%, with the most recent change of +38.17% (+46.86%) on December 31, 2023. During the last 3 years, it has fallen by -18.20% (-72.57%). LSTA annual ROE is now -103.94% below its all-time high of 1099.58%, reached on March 1, 1998.LSTA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Quarterly ROE
-50.87%
-4.65%-10.06%
30 September 2024
Summary:
As of January 23, 2025, LSTA quarterly return on equity is -50.87%, with the most recent change of -4.65% (-10.06%) on September 30, 2024. Over the past year, it has dropped by -12.98% (-34.26%). LSTA quarterly ROE is now -100.97% below its all-time high of 5267.04%, reached on December 1, 2006.LSTA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.9% | -34.3% |
| 3 y3 years | -72.6% | -34.3% |
| 5 y5 years | -1.0% | -34.3% |
LSTA ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.4% | +46.9% | -106.9% | +38.9% |
| 5 y | 5-year | -72.6% | +53.5% | -123.0% | +38.9% |
| alltime | all time | -103.9% | +97.9% | -101.0% | +98.6% |
Lisata Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -50.87%(+10.1%) |
| June 2024 | - | -46.22%(+16.4%) |
| Mar 2024 | - | -39.70%(+4.8%) |
| Dec 2023 | -43.28%(-46.9%) | -37.89%(+5.2%) |
| Sept 2023 | - | -36.01%(-56.7%) |
| June 2023 | - | -83.23%(+4.4%) |
| Mar 2023 | - | -79.71%(+13.7%) |
| Dec 2022 | -81.45%(+173.6%) | -70.08%(+6.7%) |
| Sept 2022 | - | -65.67%(+141.7%) |
| June 2022 | - | -27.17%(+10.5%) |
| Mar 2022 | - | -24.59%(-9.1%) |
| Dec 2021 | -29.77%(+18.7%) | - |
| Dec 2021 | - | -27.05%(-10.3%) |
| Sept 2021 | - | -30.15%(-12.2%) |
| June 2021 | - | -34.34%(+50.5%) |
| Mar 2021 | - | -22.81%(-15.1%) |
| Dec 2020 | -25.08%(-73.0%) | -26.88%(-4.0%) |
| Sept 2020 | - | -28.01%(-6.1%) |
| June 2020 | - | -29.84%(-63.4%) |
| Mar 2020 | - | -81.48%(+16.4%) |
| Dec 2019 | -93.01%(+117.1%) | -69.97%(+24.3%) |
| Sept 2019 | - | -56.31%(+21.5%) |
| June 2019 | - | -46.34%(+17.2%) |
| Mar 2019 | - | -39.55%(+2.8%) |
| Dec 2018 | -42.85%(-194.2%) | -38.46%(+12.5%) |
| Sept 2018 | - | -34.20%(+7.6%) |
| June 2018 | - | -31.78%(-159.0%) |
| Mar 2018 | - | 53.86%(-8.1%) |
| Dec 2017 | 45.50%(-106.8%) | 58.60%(-18.0%) |
| Sept 2017 | - | 71.43%(-25.1%) |
| June 2017 | - | 95.40%(-116.6%) |
| Mar 2017 | - | -575.13%(+55.6%) |
| Dec 2016 | -668.65%(+236.3%) | -369.60%(-16.4%) |
| Sept 2016 | - | -442.26%(+69.7%) |
| June 2016 | - | -260.54%(+46.7%) |
| Mar 2016 | - | -177.64%(+10.8%) |
| Dec 2015 | -198.84%(+117.6%) | -160.31%(+57.4%) |
| Sept 2015 | - | -101.87%(-1.6%) |
| June 2015 | - | -103.56%(+5.1%) |
| Mar 2015 | - | -98.51%(+14.4%) |
| Dec 2014 | -91.38%(+11.2%) | -86.14%(-8.7%) |
| Sept 2014 | - | -94.38%(+5.0%) |
| June 2014 | - | -89.85%(-10.6%) |
| Mar 2014 | - | -100.50%(-1.0%) |
| Dec 2013 | -82.20%(-13.7%) | -101.53%(-11.1%) |
| Sept 2013 | - | -114.21%(+10.9%) |
| June 2013 | - | -103.03%(-3.5%) |
| Mar 2013 | - | -106.80%(+19.3%) |
| Dec 2012 | -95.21%(+68.3%) | -89.53%(+15.4%) |
| Sept 2012 | - | -77.61%(+12.0%) |
| June 2012 | - | -69.32%(+34.8%) |
| Mar 2012 | - | -51.42%(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -56.58%(+75.2%) | -51.80%(+38.0%) |
| Sept 2011 | - | -37.53%(-2.8%) |
| June 2011 | - | -38.63%(+11.5%) |
| Mar 2011 | - | -34.65%(+12.4%) |
| Dec 2010 | -32.30%(-63.8%) | -30.82%(-39.5%) |
| Sept 2010 | - | -50.93%(-27.8%) |
| June 2010 | - | -70.52%(-39.4%) |
| Mar 2010 | - | -116.34%(-46.8%) |
| Dec 2009 | -89.17%(-79.8%) | -218.56%(-89.6%) |
| Sept 2009 | - | -2094.69%(+184.7%) |
| June 2009 | - | -735.76%(-1.7%) |
| Mar 2009 | - | -748.25%(+59.6%) |
| Dec 2008 | -442.27%(-23.6%) | -468.88%(+33.8%) |
| Sept 2008 | - | -350.51%(-30.9%) |
| June 2008 | - | -507.37%(+0.2%) |
| Mar 2008 | - | -506.16%(-10.9%) |
| Dec 2007 | -578.97%(-72.1%) | -567.79%(-17.1%) |
| Sept 2007 | - | -685.23%(-61.6%) |
| June 2007 | - | -1785.87%(-52.1%) |
| Mar 2007 | - | -3731.60%(-170.8%) |
| Dec 2006 | -2071.69%(-2257.8%) | 5267.04%(+616.9%) |
| Sept 2006 | - | 734.70%(+241.2%) |
| June 2006 | - | 215.31%(+56.4%) |
| Mar 2006 | - | 137.69%(+71.8%) |
| Dec 2005 | 96.01%(+6.1%) | 80.13%(+16.5%) |
| Sept 2005 | - | 68.78%(-4.9%) |
| June 2005 | - | 72.36%(-11.0%) |
| Mar 2005 | - | 81.29%(-14.5%) |
| Dec 2004 | 90.51%(+30.3%) | 95.09%(-13.3%) |
| Sept 2004 | - | 109.64%(+13.1%) |
| June 2004 | - | 96.93%(+5.2%) |
| Mar 2004 | - | 92.17%(+10.5%) |
| Dec 2003 | 69.48%(-50.6%) | 83.39%(-7.0%) |
| Sept 2003 | - | 89.70%(-22.3%) |
| June 2003 | - | 115.44%(-27.5%) |
| Mar 2003 | - | 159.27%(-50.3%) |
| Dec 2002 | 140.77%(-197.8%) | 320.17%(-136.2%) |
| Sept 2002 | - | -884.50%(+197.9%) |
| June 2002 | - | -296.96%(+64.9%) |
| Mar 2002 | - | -180.13%(+27.5%) |
| Dec 2001 | -144.00%(+126.3%) | -141.24%(+59.8%) |
| Sept 2001 | - | -88.37%(+2.0%) |
| June 2001 | - | -86.67%(+23.3%) |
| Mar 2001 | - | -70.29%(+37.3%) |
| Dec 2000 | -63.62%(+3.4%) | -51.19%(+53.1%) |
| Sept 2000 | - | -33.44%(+191.8%) |
| June 2000 | - | -11.46%(+213.1%) |
| Mar 2000 | - | -3.66% |
| Dec 1999 | -61.55%(-142.3%) | - |
| Dec 1998 | 145.42%(-86.8%) | - |
| Mar 1998 | 1099.58%(+2054.3%) | - |
| Mar 1997 | 51.04%(-109.5%) | - |
| Mar 1996 | -536.23% | - |
FAQ
- What is Lisata Therapeutics annual return on equity?
- What is the all time high annual ROE for Lisata Therapeutics?
- What is Lisata Therapeutics annual ROE year-on-year change?
- What is Lisata Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly ROE year-on-year change?
What is Lisata Therapeutics annual return on equity?
The current annual ROE of LSTA is -43.28%
What is the all time high annual ROE for Lisata Therapeutics?
Lisata Therapeutics all-time high annual return on equity is 1099.58%
What is Lisata Therapeutics annual ROE year-on-year change?
Over the past year, LSTA annual return on equity has changed by +38.17% (+46.86%)
What is Lisata Therapeutics quarterly return on equity?
The current quarterly ROE of LSTA is -50.87%
What is the all time high quarterly ROE for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly return on equity is 5267.04%
What is Lisata Therapeutics quarterly ROE year-on-year change?
Over the past year, LSTA quarterly return on equity has changed by -12.98% (-34.26%)